• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. HIMS

Hims & Hers Health, Inc.(HIMS)

New York Stock Exchange
Sector: Consumer Defensive | Industry: Household & Personal Products
Hims & Hers Health, Inc. logo

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Latest News & Analysis

Silhouettes of people at a conference table with a cityscape in the background
Jul 29, 2025

Hims & Hers Health Inc. Latest Legal Challenges and Financial Analysis - Monexa AI

Explore Hims & Hers Health's recent legal challenges, partnership termination, and robust financial growth with detailed market and financial analysis.

Read more →
Healthcare icons of a man and woman in a sleek office setting with a purple minimalist background
Jul 18, 2025

Hims & Hers Health, Inc. (HIMS) Faces Securities Fraud Lawsuit Amid Market Volatility

Hims & Hers Health, Inc. (HIMS) confronts securities fraud allegations linked to deceptive marketing, triggering sharp stock declines and investor lawsuits.

Read more →
Businesspeople at a conference table in an office, reviewing digital charts against a soft purple background
Jul 16, 2025

Hims & Hers Health, Inc. (HIMS) Legal Challenges and Financial Resilience: A Data-Driven Analysis

Explore how Hims & Hers Health, Inc. (HIMS) navigates securities fraud allegations amid strong revenue growth and improving profitability.

Read more →
Concerned investors meeting in a glass-walled office with purple minimalist decor
Jul 14, 2025

Hims & Hers Health, Inc. (HIMS) Lawsuit Impact and Financial Analysis - Monexa AI

Hims & Hers Health faces securities fraud lawsuit with significant stock volatility and financial shifts; detailed analysis of recent developments and future outlook.

Read more →
Male doctor in modern office with purple lighting, appearing thoughtful
Jul 11, 2025

Hims & Hers Health Inc. (HIMS) Faces Legal Turbulence Amid Novo Nordisk Split and Market Volatility

Hims & Hers Health (HIMS) confronts securities fraud allegations after Novo Nordisk partnership ends, causing sharp stock drop and investor scrutiny.

Read more →
Group of businesspeople in formal attire sitting at a conference table in a modern office with purple lighting accents
Jul 10, 2025

Hims & Hers Health (HIMS) Faces Legal Turbulence Amid Novo Nordisk Fallout and Strategic Shifts

Hims & Hers Health stock surges +4.66% post legal setbacks tied to Novo Nordisk partnership dispute, revealing key financial impacts and strategic pivots in 2025.

Read more →
Worried investor at desk with tablet and financial charts, city skyline softly blurred in purple tones
Jul 8, 2025

Hims & Hers Health, Inc. Latest Corporate Developments and Financial Analysis

In-depth analysis of Hims & Hers Health's recent legal challenges, partnership termination, and financial performance revealing strategic and market impacts.

Read more →
Gavel and scales of justice on modern table with soft purple gradient in background
Jul 3, 2025

Hims & Hers Health, Inc. Legal Challenges and Financial Performance Analysis

Hims & Hers faces securities fraud allegations and partnership termination with Novo Nordisk, impacting its stock and financial fundamentals.

Read more →
Business person stands in modern office with city view at dusk, bathed in soft purple lighting
Jul 2, 2025

Hims & Hers Health, Inc. (HIMS) Latest Legal Challenges and Financial Performance Analysis

Explore Hims & Hers Health, Inc.'s recent securities fraud lawsuit, partnership termination, and financial growth insights impacting investor decisions.

Read more →
Modern laptop with glowing screen showing analytics, surrounded by digital icons in a sleek purple-themed workspace
Jul 1, 2025

Hims & Hers Health, Inc. (HIMS) Latest Financial and Strategic Update

Explore Hims & Hers Health's recent financial performance, strategic moves, and market positioning with data-driven insights for investors.

Read more →
Modern laptop showing digital analytics on a sleek desk with a soft purple gradient background
Jun 30, 2025

Hims & Hers Health, Inc. Market Update: Strategic Positioning and Financial Insights

Hims & Hers Health, Inc. shows strategic momentum with solid stock performance and evolving market positioning as of June 2025.

Read more →
Hims & Hers enters weight-loss market with Zepbound: strategy, competition, and stock analysis. Explore GLP-1 subscription model, competitive landscape, telehealth regulations, and financial performance impacting investors.
Apr 9, 2025

Hims & Hers (HIMS): Weight-Loss Strategy, Competition, and Risks

Hims & Hers Health, Inc. navigates telehealth competition, expands weight-loss offerings, and faces regulatory risks. A comprehensive analysis of HIMS's strategic moves and market dynamics.

Read more →
Hims & Hers Health: Navigating market shifts, strategic diversification, and personalized healthcare solutions for sustainable growth. Learn about their latest strategies and financial performance.
Feb 24, 2025

Hims & Hers Health, Inc.: Adapting to Market Shifts and Diversifying Growth

Hims & Hers faces market shifts due to GLP-1 drug availability. Strategic acquisitions and diversification are key to navigating the evolving landscape.

Read more →
Hims & Hers logo, representing the telehealth company.
Feb 18, 2025

Hims & Hers Stock Surge: Growth Drivers and Market Outlook

Latest analysis reveals Hims & Hers's robust growth, strategic marketing, and expansion fueling its stock surge amid a competitive telehealth market.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.